Novartis | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
AbbVie USD 4.81B 1.54B 2024-12
Alcon AG USD 414M 65M 2025-03
Almirall EUR -2102000 17.27M 2024-12
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 3.4B 1.74B 2025-03
Autolus Therapeutics Ltd -82070000 23.85M 2024-09
Bayer EUR 1.83B 2.31B 2025-03
Biogen USD 572.2M 118.5M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
Fresenius EUR 611M 210M 2025-03
Fresenius Medical Care EUR 179.93M 201.07M 2024-12
Galapagos EUR -156367000 175.4M 2025-03
Genmab DKK 244M 3.36B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
GRIFOLS EUR 210.54M 143.56M 2024-12
Hikma Pharmaceutical USD 144M 144M 2024-06
J&J USD 13.63B 8.21B 2025-03
Lonza CHF 427M 167M 2024-06
Merck EUR 809M 425.38M 2024-12
Merck USD 5.22B 114M 2024-12
Novartis USD 4.66B 269M 2024-12
Novartis USD 4.66B 269M 2024-12
Novo Nordisk 34.38B 9.05B 2024-09
Orion EUR 76.8M 14.9M 2025-03
Pfizer USD 4.44B 2.36B 2024-12
Philips EUR 309M 63M 2025-03
Recordati EUR 150.03M 19.43M 2024-09
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.16B 20M 2025-03
UCB EUR 123M 464.07M 2024-06



Novartis Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.